GGrantIndex
Sort

24,576 grants matching microbiome

Elucidating Pathophysiological Mechanisms of Intestinal Inflammation

$307,844
Mark S. Silverberg · Sinai Health System · U01 · FY2021 · DK

Core 1: Translational and Clinical Resource Core

$307,791
Julian M. Mackay-Wiggan · Columbia University Health Sciences · P50 · FY2021 · AR

The influence of structural violence and individual behavior and health on the gut microbiome and colorectal cancer risk

$307,692
Lisa Tussing-Humphreys · University Of Illinois At Chicago · U54 · FY2021 · MD

Collaborative Research: Understanding spatiotemporal dynamics of plant-soil feedbacks: Consequences for shrub-grass interactions in a dryland ecotone

$307,495
Jennifer A Rudgers · University Of New Mexico · · FY2021 · BIO

Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)

$307,238
John C He · Baylor College Of Medicine · P01 · FY2017 · DK

Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities

$307,062
Hua Xie · Meharry Medical College · U54 · FY2017 · MD

Systems biology and the evolutionary dynamics in a synthetic microbial community

$306,989
William Harcombe · University Of Minnesota · R01 · FY2017 · GM

ERC Einstein Rockefeller CUNY Center for AIDS Research

$306,936
Joan Weinberger Berman · Albert Einstein College Of Medicine · P30 · FY2024 · AI

Live microbial therapeutics for enzyme replacement therapy against homocystinuria

$306,931
Joseph Moeller Schinaman · Petri Bio Llc · R43 · FY2021 · HD

Intestinal Dysbiosis Exacerbates Inflammation after Cardiopulmonary Bypass in Congenital Heart Disease

$306,928
Jeffrey Salomon · University Of Nebraska Medical Center · P20 · FY2025 · GM

Vertical Sleeve Gastrectomy for Treatment of NASH: a pilot randomized control

$306,902
Sayeed Ikramuddin · University Of Minnesota · R01 · FY2023 · DK

High-content study to analyze the nutritional value of natural products for healthy aging

$306,793
Sudip Mondal · Vivoverse, Llc · R43 · FY2025 · AT

Project 3 Identification of Microbial Founder Species and Metabolic Products that Promote Microbiota and Immune Development Resilient to Childhood Allergy and Asthma

$306,740
Susan Veronica Lynch · Henry Ford Health System · P01 · FY2021 · AI

Project 3 Identification of Microbial Founder Species and Metabolic Products that Promote Microbiota and Immune Development Resilient to Childhood Allergy and Asthma

$306,740
Susan Veronica Lynch · Henry Ford Health System · P01 · FY2022 · AI

Project 3 Identification of Microbial Founder Species and Metabolic Products that Promote Microbiota and Immune Development Resilient to Childhood Allergy and Asthma

$306,740
Susan Veronica Lynch · Henry Ford Health System · P01 · FY2024 · AI

Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk

$306,664
H. Rex Gaskins · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA

Adaptation to diet and its impact on the gut microbiome and genomic variation

$306,600
Sarah A Tishkoff · University Of Pennsylvania · · FY2013 · SBE

Vaginal ring for sustained release of lactic acid to prevent bacterial vaginosis and associated health risks

$306,500
Richard A Cone · Mucommune, Llc · R43 · FY2021 · AI

A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis

$306,499
Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · AI

Highly Acidifying Intravaginal Rings with Lactobacillus Probiotics to Treat Bacterial Vaginosis

$306,483
Keiichiro Kushiro · Mucommune, Llc · R43 · FY2023 · AI

THE T-CELL RECEPTOR'S ROLE IN T-CELL LYMPHOMA PATHOGENESIS

$306,482
Ryan A Wilcox · University Of Michigan At Ann Arbor · R37 · FY2024 · CA

A Novel Small Molecule for the Treatment of Periodontitis

$306,463
Neil A Fanger · Virtici, Llc · R43 · FY2022 · DE

Natural Product HCV Drugs from Rare Plant-Microbe Interactions

$306,423
Mark T Hamann · University Of Mississippi · R01 · FY2014 · AT

Natural Product HCV Drugs from Rare Plant-Microbe Interactions

$306,422
Mark T Hamann · University Of Mississippi · R01 · FY2013 · AT

A Novel Small Molecule for the Treatment of Periodontitis

$306,391
Neil A Fanger · Virtici, Llc · R43 · FY2023 · DE